2024-03-01 2025-02-28 2025-02-28 Trading false The accounts were prepared in accordance with frs102 There is no accountants report AbridgedAccounts This company is a private limited company 10003389 2025-02-28 10003389 2024-02-29 10003389 2023-02-28 10003389 2024-03-01 2025-02-28 10003389 2023-03-01 2024-02-29 10003389 uk-cd-pres:AllEntityOfficers 2024-03-01 2025-02-28 10003389 uk-cd-pres:AllEntityOfficers 2023-03-01 2024-02-29 10003389 uk-cd-pres:CompanySecretary1 2024-03-01 2025-02-28 10003389 uk-cd-pres:CompanySecretaryDirector1 2024-03-01 2025-02-28 10003389 uk-cd-pres:CompanySecretaryDirector1 2025-02-28 10003389 uk-cd-pres:Director1 2024-03-01 2025-02-28 10003389 uk-cd-pres:Director1 2025-02-28 10003389 uk-cd-pres:AllOrdinaryShares 2025-02-28 10003389 uk-cd-pres:AllPreferenceShares 2025-02-28 10003389 uk-cd-pres:AllOrdinaryShares 2024-02-29 10003389 uk-cd-pres:AllPreferenceShares 2024-02-29 10003389 uk-cd-pres:AllOrdinaryShares 2024-03-01 2025-02-28 10003389 uk-cd-pres:AllPreferenceShares 2024-03-01 2025-02-28 10003389 uk-cd-pres:AllOrdinaryShares 2023-03-01 2024-02-29 10003389 uk-cd-pres:AllPreferenceShares 2023-03-01 2024-02-29 10003389 uk-cd-pres:RegisteredOffice 2024-03-01 2025-02-28 10003389 uk-cd-pres:EntityAccountantsOrAuditors 2025-02-28 10003389 uk-cd-pres:EntityAccountantsOrAuditors 2024-03-01 2025-02-28 10003389 uk-cd-pres:EntityAccountantsOrAuditors 2023-03-01 2024-02-29 10003389 uk-cd-pres:EntityBankers 2024-03-01 2025-02-28 10003389 uk-cd-pres:EntityLawyersOrLegalAdvisers 2024-03-01 2025-02-28 10003389 uk-countries:UnitedKingdom 2024-03-01 2025-02-28 10003389 uk-countries:Europe 2024-03-01 2025-02-28 10003389 uk-countries:NorthAmerica 2024-03-01 2025-02-28 10003389 uk-countries:OtherCountriesRegions 2024-03-01 2025-02-28 10003389 uk-countries:UnitedKingdom 2023-03-01 2024-02-29 10003389 uk-countries:Europe 2023-03-01 2024-02-29 10003389 uk-countries:NorthAmerica 2023-03-01 2024-02-29 10003389 uk-countries:OtherCountriesRegions 2023-03-01 2024-02-29 10003389 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2024-03-01 2025-02-28 10003389 uk-gaap-pt:LeasedTangibleFixedAssets 2024-03-01 2025-02-28 10003389 uk-gaap-pt:OwnedOrFreeholdTangibleFixedAssets 2023-03-01 2024-02-29 10003389 uk-gaap-pt:LeasedTangibleFixedAssets 2023-03-01 2024-02-29 10003389 uk-gaap-pt:OwnedAssets 2024-03-01 2025-02-28 10003389 uk-gaap-pt:LeasedAssets 2024-03-01 2025-02-28 10003389 uk-gaap-pt:OwnedAssets 2023-03-01 2024-02-29 10003389 uk-gaap-pt:LeasedAssets 2023-03-01 2024-02-29 10003389 uk-gaap-pt:LeasedAssetsHeldAsLessee 2025-02-28 10003389 uk-gaap-pt:LeasedAssetsHeldAsLessee 2024-02-29 10003389 uk-gaap-pt:LeasedAssetsHeldAsLessee 2024-03-01 2025-02-28 10003389 uk-gaap-pt:LeasedAssetsHeldAsLessee 2023-03-01 2024-02-29 10003389 uk-gaap-pt:NetGoodwill 2024-02-29 10003389 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2024-02-29 10003389 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2024-02-29 10003389 uk-gaap-pt:OtherResidualIntangibleAssets 2024-02-29 10003389 uk-gaap-pt:NetGoodwill 2024-03-01 2025-02-28 10003389 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2024-03-01 2025-02-28 10003389 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2024-03-01 2025-02-28 10003389 uk-gaap-pt:OtherResidualIntangibleAssets 2024-03-01 2025-02-28 10003389 uk-gaap-pt:NetGoodwill 2025-02-28 10003389 uk-gaap-pt:RecipesFormulaeModelsDesignsPrototypes 2025-02-28 10003389 uk-gaap-pt:CopyrightsPatentsTrademarksServiceOperatingRights 2025-02-28 10003389 uk-gaap-pt:OtherResidualIntangibleAssets 2025-02-28 10003389 uk-gaap-pt:Buildings 2024-03-01 2025-02-28 10003389 uk-gaap-pt:Land 2024-03-01 2025-02-28 10003389 uk-gaap-pt:LandBuildings 2024-02-29 10003389 uk-gaap-pt:PlantMachinery 2024-02-29 10003389 uk-gaap-pt:FurnitureFittings 2024-02-29 10003389 uk-gaap-pt:FurnitureFittings 2024-02-29 10003389 uk-gaap-pt:OfficeEquipment 2024-02-29 10003389 uk-gaap-pt:Vehicles 2024-02-29 10003389 uk-gaap-pt:LandBuildings 2024-03-01 2025-02-28 10003389 uk-gaap-pt:PlantMachinery 2024-03-01 2025-02-28 10003389 uk-gaap-pt:FurnitureFittings 2024-03-01 2025-02-28 10003389 uk-gaap-pt:FurnitureFittings 2024-03-01 2025-02-28 10003389 uk-gaap-pt:OfficeEquipment 2024-03-01 2025-02-28 10003389 uk-gaap-pt:Vehicles 2024-03-01 2025-02-28 10003389 uk-gaap-pt:LandBuildings 2025-02-28 10003389 uk-gaap-pt:PlantMachinery 2025-02-28 10003389 uk-gaap-pt:FurnitureFittings 2025-02-28 10003389 uk-gaap-pt:OfficeEquipment 2025-02-28 10003389 uk-gaap-pt:Vehicles 2025-02-28 10003389 uk-gaap-ptx:AdministrativeExpenses 2024-03-01 2025-02-28 10003389 uk-gaap-ptx:AdministrativeExpenses 2023-03-01 2024-02-29 10003389 uk-gaap-ptx:CostSales 2024-03-01 2025-02-28 10003389 uk-gaap-ptx:CostSales 2023-03-01 2024-02-29 10003389 uk-gaap-ptx:DistributionCosts 2024-03-01 2025-02-28 10003389 uk-gaap-ptx:DistributionCosts 2023-03-01 2024-02-29 10003389 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2025-02-28 10003389 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2024-02-29 10003389 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2025-02-28 10003389 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:ListedExchangeTraded 2024-02-29 10003389 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2025-02-28 10003389 uk-gaap-pt:CurrentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2024-02-29 10003389 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2025-02-28 10003389 uk-gaap-pt:Non-currentFinancialInstruments uk-gaap-pt:UnlistedNon-exchangeTraded 2024-02-29 10003389 uk-gaap-pt:CurrentFinancialInstruments 2025-02-28 10003389 uk-gaap-pt:CurrentFinancialInstruments 2024-02-29 10003389 uk-gaap-pt:WithinOneYear 2025-02-28 10003389 uk-gaap-pt:BetweenOneTwoYears 2025-02-28 10003389 uk-gaap-pt:BetweenTwoFiveYears 2025-02-28 10003389 uk-gaap-pt:MoreThanFiveYears 2025-02-28 10003389 uk-gaap-pt:AfterOneYear 2025-02-28 10003389 uk-gaap-pt:WithinOneYear 2024-02-29 10003389 uk-gaap-pt:BetweenOneTwoYears 2024-02-29 10003389 uk-gaap-pt:BetweenTwoFiveYears 2024-02-29 10003389 uk-gaap-pt:MoreThanFiveYears 2024-02-29 10003389 uk-gaap-pt:AfterOneYear 2024-02-29 10003389 uk-gaap-pt:ShareCapital 2025-02-28 10003389 uk-gaap-pt:SharePremium 2025-02-28 10003389 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2025-02-28 10003389 uk-gaap-pt:RevaluationReserve 2025-02-28 10003389 uk-gaap-pt:OtherReservesSubtotal 2025-02-28 10003389 uk-gaap-pt:ShareCapital 2024-02-29 10003389 uk-gaap-pt:SharePremium 2024-02-29 10003389 uk-gaap-pt:RetainedEarningsAccumulatedLosses 2024-02-29 10003389 uk-gaap-pt:RevaluationReserve 2024-02-29 10003389 uk-gaap-pt:OtherReservesSubtotal 2024-02-29 10003389 1 2024-03-01 2025-02-28 10003389 2 2024-03-01 2025-02-28 10003389 uk-cd-pres:FRS102 2024-03-01 2025-02-28 10003389 uk-cd-pres:AuditExempt-NoAccountantsReport 2024-03-01 2025-02-28 10003389 uk-cd-pres:FullAccounts 2024-03-01 2025-02-28 10003389 uk-cd-pres:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 iso4217:GBP xbrli:pure

The Implant Lab Limited |  |  |  |  |
Company Registration Number |  |  |  |  |
10003389 |  |  |  |  |  |  |
Report of the Directors and |  |  |  |  |
Abridged Unaudited Financial Statements |  |  |  |
Period of accounts |  |  |  |  |  |
Start date 01/03/2024 |  |  |  |  |
End date 28/02/2025 |  |  |  |  |  |
|  |  |  |  |  |  | Page 1

The Implant Lab Limited |  |  |  |  |
Contents of the Financial Statements |  |  |  |
for the Period Ended 28 February 2025 |  |  |  |
|  |  |  |  |  |  | Page
Company Information |  |  |  |  |  | 3
Abridged Balance Sheet |  |  |  |  | 4 - 5
Notes to the Financial Statements |  |  |  | 6 - 7
|  |  |  |  |  |  | Page 2

The Implant Lab Limited |  |  |  |  |
Company Information |  |  |  |  |  |
for the Period Ended 28 February 2025 |  |  |  |
Directors |  |  |  | A Davies |  |  |
Company secretary |  |  | M Davies |  |  |
Registered office |  |  | 52 Ardwick Green South |  |  |
|  |  |  | Manchester |  |  |
|  |  |  | M13 9XF |  |  |
Company Registration Number |  | 10003389 |  |  |
|  |  |  |  |  |  | Page 3

The Implant Lab Limited |  |  |  |  |
Balance Sheet |  |  |  |  |  |
for the Period Ended 28 February 2025 |  |  |  |
Company registration number 10003389 |  |  |  |
|  |  |  |  |  | 2025 | 2,024
|  |  |  |  | Notes | £ | £
Fixed assets |  |  |  |  |  |
Tangible fixed assets |  |  |  | 2,011 | 2,681
|  |  |  |  |  | _______ | _______
Total fixed assets |  |  |  |  | 2,011 | 2,681
Current assets |  |  |  |  |  |
Debtors |  |  |  |  |  | 500,000 | 545,723
Cash at bank and in hand |  |  |  | 353,896 | 195,657
|  |  |  |  |  | _______ | _______
Total current assets/(liabilities) |  |  | 853,896 | 741,380
Creditors |  |  |  |  |  |  |
Creditors - amounts falling |  |  |  |  |
due within one year |  |  |  |  | 264,936 | 308,696
|  |  |  |  |  | _______ | _______
Net current assets |  |  |  |  | 588,960 | 432,684
|  |  |  |  |  | _______ | _______
Total assets less current liabilities |  |  | 590,971 | 435,365
|  |  |  |  |  | _______ | _______
Net assets/(liabilities) |  |  |  | 590,971 | 435,365
Capital and reserves |  |  |  |  |  |
Called up share capital |  |  | 2 | 100 | 100
Profit and loss account |  |  |  | 590,871 | 435,265
|  |  |  |  |  | ______ | ______
Total shareholders funds |  |  |  | 590,971 | 435,365
|  |  |  |  |  |  | Page 4

The Implant Lab Limited |  |  |  |  |  |
Balance Sheet |  |  |  |  |  |  |
for the Period Ended 28 February 2025 |  |  |  |  |
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The option not to file the profit and loss account has been taken. |  |
For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements were approved by the Board of Directors on | 2025-11-18 |
SIGNED ON BEHALF OF THE BOARD BY |  |  |  |  |
Name | A Davies |  |  |  |  |  |  |
The notes form part of these financial statements |  |  |  |
Average number of employees during period | 0 |  |  |
|  |  |  |  |  |  | Page 5 |

The Implant Lab Limited |  |  |  |  |  |
Notes to the Financial Statements |  |  |  |  |
for the Period Ended 28 February 2025 |  |  |  |  |
1. Accounting policies |  |  |  |  |  |
Basis of preparation |  |  |  |  |  |  |
The financial statements have been prepared under the historical cost convention and in accordance with the small companies regime.
Tangible fixed assets Depreciation |  |  |  |  |
Depreciation is provided, after taking account of any grants receivable, at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery |  | 25% reducing balance |  |  |  |  |
|  |  |  |  |  |  | Page 6 |

The Implant Lab Limited |  |  |  |  |
Notes to the Financial Statements |  |  |  |
for the Period Ended 28 February 2025 |  |  |  |
2. Share capital |  |  |  |  | 2025 | 2,024
Authorised type |  |  | Par value |  | £ | £
Ordinary |  |  |  | 1 |  | 100 | 100
|  |  |  |  |  | ___ | ___
Total |  |  |  |  |  | 100 | 100
Allotted, called up and paid |  |  |  | £ | £
Ordinary |  |  |  |  |  | 100 | 100
|  |  |  |  |  | ___ | ___
Total |  |  |  |  |  | 100 | 100
|  |  |  |  |  |  | Page 7